RISK ASSESSMENT OF NEW PSYCHOACTIVE SUBSTANCES. OPERATING GUIDELINES

Đã lưu trong:

Chi tiết về thư mục
Tác giả của công ty:	EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION
Định dạng:	Monograph
Ngôn ngữ:	Tiếng Anh
Được phát hành:	LISBOA EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION 2009
Những chủ đề:	Detección Drogodependencias Efectos Enfermedad Evaluación Impacto social Informes oficiales Innovaciones Manuales Recomendaciones Resultados Riesgo Salud Adicciones Documental
Truy cập trực tuyến:	Path Enlace web
Các nhãn:	Thêm thẻ Không có thẻ, Là người đầu tiên thẻ bản ghi này!

Những quyển sách tương tự: RISK ASSESSMENT OF NEW PSYCHOACTIVE SUBSTANCES. OPERATING GUIDELINES

Quick Look
EMCDDA operating guidelines for the risk assessment of new psychoactive substances
Quick Look
EARLY-WARNING SYSTEM ON NEW PSYCHOACTIVE SUBSTANCES. OPERATING GUIDELINES
Quick Look
Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances
Quick Look
RISK ASSESSMENT REPORT OF A NEW PSYCHOACTIVE SUBSTANCE: 4-METHYLMETHCATHINONE (MEPHEDRONE) IN ACCORDANCE WITH ARTICLE 6 OF COUNCIL DECISION 2005/387/JHA ON INFORMATION EXCHANGE, RISK ASSESSMENT AND CONTROL OF NEW PSYCHOACTIVE SUBSTANCES
Quick Look
EMCDDA operating guidelines for the European Union Early Warning System on new psychoactive substances
Quick Look
EMCDDA-Europol Joint Report on a new psychoactive substance: 5-(2-aminopropyl)indole. In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances
Quick Look
4-Methylamphetamine (4-MA). Report on the risk assessment of 4-methylamphetamine in the framework of the Council Decision on new psychoactive substances
Quick Look
EMCDDA-Europol 2013 Annual Report on the implementation of Council Decision 2005/387/JHA. In accordance with Article 10 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances
Quick Look
5-(2-Aminopropyl)indole (5-IT). Report on the risk assessment of 5-(2-aminopropyl)indole in the framework of the Council Decision on new psychoactive substances
Quick Look
AGED CARE ASSESSMENT PROGRAM. OPERATIONAL GUIDELINES
Quick Look
EMCDDA-Europol Joint Report on a new psychoactive substance: 4,4'-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine)
Quick Look
REPORT ON THE RISK ASSESSMENT OF MBDB IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS. GUIDELINES FOR THE RISK ASSESSMENT OF NEW SYNTHETIC DRUGS
Quick Look
INTERNATIONAL GUIDELINES FOR THE EVALUATION OF TREATMENT SERVICES AND SYSTEMS FOR PSYCHOACTIVE SUBSTANCE USE DISORDERS.
Quick Look
DRUG MISUSE AND DEPENDENCE- GUIDELINES ON CLINICAL MANAGEMENT
Quick Look
EMCDDA-Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone)
Quick Look
Can new psychoactive substances be regulated effectively? An assessment of the British Psychoactive Substances Bill
Quick Look
Consideration of the novel psychoactive substances ('legal highs')
Quick Look
EMCDDA-Europol Joint Report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone)
Quick Look
THE SUBSTANCE ABUSE PROFESSIONAL GUIDELINES
Quick Look
New psychoactive substances: Are there any good options for regulating new psychoactive substances?
Quick Look
EMCDDA–Europol Joint Report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (‘MT-45’)
Quick Look
ASSESSMENT. EN: DRUG MISUSE AND DEPENDENCE- GUIDELINES ON CLINICAL MANAGEMENT.
Quick Look
REPORT ON THE RISK ASSESSMENT OF BZP IN THE FRAMEWORK OF THE COUNCIL DECISION ON NEW PSYCHOACTIVE SUBSTANCES
Quick Look
Assessing the ‘added value’ of European policy on new psychoactive substances